Insider · CIK 0001411874

FRIEDMAN CATHY

Reports to the SEC for 9 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001411874

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	LYELLyell Immunopharma, Inc. · Option (right to buy)A Award	Director	AAward	+9,250 sh	—	—	9,250
2025-05-15	LYELLyell Immunopharma, Inc. · Option (right to buy)A Award	Director	AAward	+130K sh	—	—	130,000
2024-06-14	LYELLyell Immunopharma, Inc. · Option (right to buy)A Award	Director	AAward	+130K sh	—	—	130,000
2023-09-08	LYELLyell Immunopharma, Inc. · Option (right to buy)A Award	Director	AAward	+55K sh	—	—	55,000
2023-06-16	LYELLyell Immunopharma, Inc. · Option (right to buy)A Award	Director	AAward	+65K sh	—	—	65,000
2023-06-14	SEERSeer, Inc. · Stock Option (right to buy)A Award	Director	AAward	+34.7K sh	—	—	34,735
2023-06-14	SEERSeer, Inc.A Award	Director	AAward	+23.4K sh	—	—	173,574
2022-08-15	Radius Health, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	$3.60	−$36K	0
2022-08-15	Radius Health, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−26.8K sh	$10.00	−$268K	0
2022-06-15	SEERSeer, Inc. · Stock Option (right to buy)A Award	Director	AAward	+29.6K sh	—	—	29,640
2022-06-15	SEERSeer, Inc.A Award	Director	AAward	+9,945 sh	—	—	150,131
2022-06-08	LYELLyell Immunopharma, Inc. · Option (right to buy)A Award	Director	AAward	+65K sh	—	—	65,000
2022-01-14	Radius Health, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2022-01-14	Radius Health, Inc.A Award	Director	AAward	+5,500 sh	—	—	26,800
2021-12-14	LYELLyell Immunopharma, Inc.J Other	Director	JOther	−3.77M sh	—	—	0
2021-12-14	LYELLyell Immunopharma, Inc.J Other	Director	JOther	+219K sh	—	—	236,370
2021-06-21	LYELLyell Immunopharma, Inc. · Series A Convertible Preferred StockC Conversion	Director	CConversion	−3.77M sh	—	—	0
2021-06-21	LYELLyell Immunopharma, Inc.P Purchase	Director	PPurchase	+17.6K sh	$17.00	+$300K	17,648
2021-06-21	LYELLyell Immunopharma, Inc.C Conversion	Director	CConversion	+3.77M sh	—	—	3,765,842
2021-06-17	SEERSeer, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-02-22	Radius Health, Inc.A Award	Director	AAward	+5,500 sh	—	—	21,300
2021-02-22	Radius Health, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-01-21	Radius Health, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-12-03	SEERSeer, Inc. · Stock Option (right to buy)A Award	Director	AAward	+18.7K sh	—	—	18,691
2020-02-20	Radius Health, Inc.A Award	Director	AAward	+5,500 sh	—	—	15,800
2020-02-20	Radius Health, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-02-22	Radius Health, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-02-22	Radius Health, Inc.A Award	Director	AAward	+5,500 sh	—	—	10,300
2019-02-13	Radius Health, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,800 sh	—	—	4,800
2019-02-13	Radius Health, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,800 sh	—	—	0
2018-02-13	Radius Health, Inc.Restricted Stock UnitsA Award	Director	AAward	+4,800 sh	—	—	4,800
2018-02-13	Radius Health, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+8,800 sh	—	—	8,800
2017-06-13	ALTABA INC.Cash-Settled Restricted Stock UnitsA Award	Director	AAward	+8,545 sh	—	—	8,545
2017-06-13	ALTABA INC.D Disposition to Issuer	Director	DDisposition to Issuer	−8,545 sh	—	—	0
2017-04-20	INVAInnoviva, Inc.A Award	Director	AAward	+19.9K sh	—	—	73,805
2017-02-17	Radius Health, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+27.5K sh	—	—	27,500
2016-07-05	XENOPORT INCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	$7.03	−$105K	0
2016-07-05	XENOPORT INCU Disposition from Tender	Director	UDisposition from Tender	−22.3K sh	$7.03	−$157K	0
2016-07-05	XENOPORT INCU Disposition from Tender	Director	UDisposition from Tender	−2,600 sh	$7.03	−$18.3K	0
2016-07-05	XENOPORT INCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	$7.03	−$105K	0
2016-07-05	XENOPORT INCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	$7.03	−$105K	0
2016-07-05	XENOPORT INCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	$7.03	−$105K	0
2016-07-05	XENOPORT INCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	$7.03	−$105K	0
2016-07-05	XENOPORT INCRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	$7.03	−$35.2K	0
2016-06-30	ALTABA INC.A Award	Director	AAward	+6,389 sh	—	—	8,545
2016-05-24	Radius Health, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+27.5K sh	—	—	27,500
2016-05-17	XENOPORT INCNon-Employee Restricted Stock UnitsA Award	Director	AAward	+5,000 sh	—	—	5,000
2016-05-17	XENOPORT INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	—	—	22,300
2016-05-17	XENOPORT INCNon-Employee Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2016-05-17	XENOPORT INCNon-Employee Stock OptionsA Award	Director	AAward	+15K sh	—	—	15,000

Recent filings

Accepted (ET)
Jun 124
FRIEDMAN CATHY0001411874-26-000002
SEC(opens sec.gov)
May 194
FRIEDMAN CATHY0001415889-25-013712
SEC(opens sec.gov)
Jun 174
FRIEDMAN CATHY0001415889-24-017146
SEC(opens sec.gov)
Sep 84
FRIEDMAN CATHY0001209191-23-048785
SEC(opens sec.gov)
Jun 204
FRIEDMAN CATHY0001209191-23-038437
SEC(opens sec.gov)
Jun 164
FRIEDMAN CATHY0001209191-23-038186
SEC(opens sec.gov)
Aug 154
FRIEDMAN CATHY0000899243-22-028642
SEC(opens sec.gov)
Jun 174
FRIEDMAN CATHY0001209191-22-038080
SEC(opens sec.gov)
Jun 104
FRIEDMAN CATHY0001209191-22-035837
SEC(opens sec.gov)
Jan 254
FRIEDMAN CATHY0001209191-22-004785
SEC(opens sec.gov)
Dec 144
FRIEDMAN CATHY0001209191-21-069485
SEC(opens sec.gov)
Jun 234
FRIEDMAN CATHY0001209191-21-042795
SEC(opens sec.gov)
Jun 224
FRIEDMAN CATHY0001209191-21-042500
SEC(opens sec.gov)

Companies

Address

C/O LYELL IMMUNOPHARMA, INC. 201 HASKINS WAY, SUITE 101

SOUTH SAN FRANCISCO, CA, 94080